Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and ...

Refractive cataract surgery has been transformed by advanced IOL technology, including extended and full-range vision lenses, ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...

Brazilian researchers conducted a study comparing two treatments for postoperative endophthalmitis. They found that pars ...

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision. According to the company, ...

To create lasting change, ophthalmology must embrace the impact of sponsorship and advocacy—empowering the next generation of ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

The funding will help fund phase 1 and phase 2 proof-of-concept studies for lead candidates CTX203 and CTX114.